Debt-to-equity in % of Twist Bioscience Corp from Q2 2019 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Twist Bioscience Corp quarterly Debt-to-equity history and change rate from Q2 2019 to Q3 2025.
  • Twist Bioscience Corp Debt-to-equity for the quarter ending 30 Sep 2025 was 34.8 %, a 28.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Twist Bioscience Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 34.8 +7.62 +28.1% 30 Sep 2025
Q2 2025 33.3 +7.46 +28.9% 30 Jun 2025
Q1 2025 32.1 +7.77 +32% 31 Mar 2025
Q4 2024 29.5 +6.25 +26.9% 31 Dec 2024
Q3 2024 27.2 +4.48 +19.8% 30 Sep 2024
Q2 2024 25.9 +3.81 +17.3% 30 Jun 2024
Q1 2024 24.3 +3.26 +15.5% 31 Mar 2024
Q4 2023 23.2 +2.97 +14.6% 31 Dec 2023
Q3 2023 22.7 +1.73 +8.26% 30 Sep 2023
Q2 2023 22 +1.33 +6.42% 30 Jun 2023
Q1 2023 21.1 +0.38 +1.84% 31 Mar 2023
Q4 2022 20.3 +1.39 +7.36% 31 Dec 2022
Q3 2022 21 +6.18 +41.8% 30 Sep 2022
Q2 2022 20.7 +6.96 +50.6% 30 Jun 2022
Q1 2022 20.7 +7.95 +62.4% 31 Mar 2022
Q4 2021 18.9 +3.56 +23.2% 31 Dec 2021
Q3 2021 14.8 -11 -42.6% 30 Sep 2021
Q2 2021 13.7 -14.3 -50.9% 30 Jun 2021
Q1 2021 12.7 -18.1 -58.8% 31 Mar 2021
Q4 2020 15.3 -17.5 -53.4% 31 Dec 2020
Q3 2020 25.7 +5.76 +28.8% 30 Sep 2020
Q2 2020 28 -19.3 -40.8% 30 Jun 2020
Q1 2020 30.9 31 Mar 2020
Q4 2019 32.9 31 Dec 2019
Q3 2019 20 30 Sep 2019
Q2 2019 47.3 30 Jun 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.